Breaking News

Chinese CDMO GenScript Breaks Ground

The GenScript-Legend Biotech Commercial Manufacturing Center to become China’s largest dedicated to cell and gene therapy research

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GenScript Biotech, a Chinese biopharmaceutical contract development and manufacturing organization (CDMO), held the groundbreaking ceremony for the start of construction of the GenScript-Legend Biotech Commercial Manufacturing Center.   The groundbreaking ceremony for the project was held in Zhenjiang on April 10, 2019, with officials of the Zhenjiang municipal government, leading experts in cell therapy, as well as partners and executives of GenScript, including GenScript subsidiary Legend Biot...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters